Stocktoria
Pulmonx Corp LUNG
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-10-01
Pulmonx Corp financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $90.5M | $83.8M | $68.7M | $53.7M | $48.4M |
| Gross profit | $67.1M | $62.0M | $50.8M | $39.9M | $35.6M |
| R&D expense | $19.5M | $17.6M | $18.1M | $15.4M | $13.1M |
| SG&A expense | $101.3M | $102.1M | $94.6M | $83.1M | $69.9M |
| Operating income | -$53.7M | -$57.7M | -$61.9M | -$58.6M | -$47.3M |
| Interest expense | — | — | $3.2M | $1.1M | $829,000 |
| Income tax | $626,000 | $500,000 | $571,000 | $353,000 | $343,000 |
| Net income | -$54.0M | -$56.4M | -$60.8M | -$58.9M | -$48.7M |
| EPS (diluted) | $-1.33 | $-1.44 | $-1.60 | $-1.59 | $-1.35 |
| Operating cash flow | -$32.4M | -$31.5M | -$37.6M | -$45.1M | -$41.4M |
| Free cash flow | -$32.8M | -$33.0M | -$38.4M | -$46.4M | -$45.1M |
| Cash & equivalents | $69.8M | $70.9M | $83.5M | $101.7M | $148.5M |
| Inventory | $15.8M | $16.9M | $16.7M | $14.6M | $16.3M |
| Total assets | $129.3M | $162.8M | $177.8M | $193.7M | $235.2M |
| Total liabilities | $75.2M | $77.0M | $59.5M | $39.7M | $41.9M |
| Shareholders' equity | $54.1M | $85.8M | $118.3M | $154.0M | $193.2M |
Source: SEC EDGAR filings · CIK 0001127537 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.